Application of β-1,3-glucan in production of ceramics-based elastic composite for bone repair

Central European Journal of Biology

Volumn 8, Issue 6, 2013, Pages 534-548

  Belcarz, Anna ^a   Ginalska, Grazyna ^a   Pycka, Teodozja ^a   Zima, Aneta ^b   Ślósarczyk, Anna ^b   Polkowska, Izabela ^c   Paszkiewicz, Zofia ^b   Piekarczyk, Wojciech ^b  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b AGH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Poland)

^c UNIVERSITY OF LIFE SCIENCES IN LUBLIN   (Poland)

Author keywords

Bioactivity; Bone filler; Hydroxyapatite ceramics; Sorption index; Sterility

Indexed keywords

EID: 84875044282     PISSN: 1895104X     EISSN: 16443632     Source Type: Journal    
DOI: 10.2478/s11535-013-0169-2     Document Type: Article

References (59)

1. Jarcho M., Kay J. F., Gumar K. I., Doremus R. H., Drobeck H. P., Tissue, cellular and subcellular events at a bone-ceramic hydroxyapatite interface, J. Biosci. Bioeng., 1977, 1, 79-91.
2. Kokubo T., Kim H.-M., Kawashita M., Novel bioactive materials with different mechanical properties, Biomaterials, 2003, 24, 2161-2175.
3. Sopyan I., Mel M., Ramesh S., Khalid K. A., Porous hydroxyapatite for artificial bone applications, Sci. Tech. Adv. Mater., 2007, 8, 116-123.
4. Sudo A., Hasegawa M., Fukuda A., Uchida A., Treatment of infected hip arthroplasty with antibiotic-impregnated calcium hydroxyapatite, J. Arthroplasty, 2008, 23, 145-150.
5. Chu Ch., Guo J., Qu J., Hu X., Efficient destruction of bacteria with Ti(IV) and antibacterial ions in cosubstituted hydroxyapatite films, Appl. Cat., 2007, 73, 345-353.
6. Yoshikawa M., Tsuji N., Toda T., Ohgushi H., Osteogenic effect of hyaluronic acid sodium salt in the pores of a hydroxyapatite scaffold, Mat. Sci. Engn., 2007, 27, 220-226.
7. Joosten U., Joist A., Gosheger G., Liljenqvist U., Brandt B., von Eiff Ch., Effectiveness of hydroxyapatite-vancomycin bone cement in the treatment of Staphylococcus aureus induced chronic osteomyelitis, Biomaterials, 2005, 26, 5251-5258.
8. Tian X. B., Wang Z. M., Yang S. Q., Luo Z. J., Fu R. K. Y., Chu P. K., Antibacterial copper-containing titanium nitride films produced by dual magnetron sputtering, Surf. Coat. Technol., 2007, 201, 8606-8609.
9. Netz D. J. A., Sepulveda P., Pandolfelli V. C., Spadaro A. C. C., Alencastre J. B., Bentley M. V. L. B., et al., Potential use of gelcasting hydroxyapatite porous ceramic as implantable drug delivery system, Int. J. Pharm., 2001, 213, 117-125.
10. Nair M. B., Babu S. S., Varma H. K., John A., A triphasic ceramic-coated porous hydroxyapatite for tissue engineering application, Acta Biomat., 2008, 4, 173-181.
11. Tsioptsias C., Panayiotou C., Preparation of cellulose-nanohydroxyapatite composite scaffolds from ionic liquid solutions, Carbohydr. Polymers, 2008, 74, 99-105.
12. Xu Q., Tanaka Y., Czernuszka J. T., Encapsulation and release of a hydrophobic drug from hydroxyapatite coated liposomes, Biomaterials, 2007, 28, 2687-2694.
13. Bharati S., Soundrapandian Ch., Basu D., Datta D., Studies on a novel bioactive glass and composite coating with hydroxyapatite on titanium based alloys: Effect of Γ-sterilization on coating, J. Eur. Cer. Society, 2009, 29, 2527-2535.
14. Shor L., Güçeri S., Wen X., Gandhi M., Sun W., Fabrication of three-dimensional polycaprolactone/hydroxyapatite tissue scaffolds and osteoblastscaffold interactions in vitro, Biomaterials, 2007, 28, 5291-5297.
15. Porter A. E., Botelho C. M., Lopes M. A., Santos J. D., Best S. M., Bonfield W., Ultrastructural comparison of dissolution and apatite precipitation on hydroxyapatite and silicon-substituted hydroxyapatite in vitro and in vivo, J. Biomed. Mater. Res. A., 2004, 69, 670-679.
16. Chang B.-S., Lee C.-K., Hong K.-S., Youn H.-J., Ryu H.-S., Chung S.-S., et al., Osteoconduction at porous hydroxyapatite with various pore configurations, Biomaterials, 2000, 21, 1291-1298.
17. Esteban S. L., Suarez T. R., Betegón F. E., Pecharromán C., Moya J. S., Mechanical properties and interfaces of zirconia/nickel in micro- and nanocomposites, J. Mater. Sci., 2006, 41, 5194-5199.
18. Le Nihouannen D., Le Guehennec L., Rouillon P., Bilban M., Layrolle P., Daculsi G., Microarchitecture of calcium phosphate granules and fibrin flue composites for bone tissue engineering, Biomaterials, 2006, 27, 2716-2722.
19. Le Nihouannen D., Saffarzadeh A., Aguado E., Goyenvalle E., Gauthier O., Moreau F., et al., Osteogenic properties of calcium phosphate ceramics and fibrin glue based composites, J. Mater. Sci. Mater. Med., 2007, 18, 225-235.
20. Zhan X.-B., Lin Ch.-Ch., Zhang H.-T., Recent advances in curdlan biosynthesis, biotechnological production and applications, Appl. Microbiol. Biotechnol., 2012, 93, 525-531.
21. Kanke M., Katayama H., Nakamura M., Application of curdlan to controlled drug delivery. III. Drug release from sustained release suppositories in vitro, Biol. Pharm. Bull., 1995, 18, 1104-1108.
22. Kanke M., Tanabe E., Katayama H., Koda Y., Nakamura M., Application of curdlan to controlled drug delivery. II. In vitro and in vivo drug release studies of theophylline-containing curdlan tablets, Biol. Pharm. Bull., 1995, 18, 1154-1158.
23. Subedi R. K., Kang K. W., Choi H.-K., Preparation and characterization of solid lipid nanoparticles loaded with doxorubicin, Eur. J. Pharm. Sci., 2009, 37, 508-513.
24. Li L., Gao F. P., Tang H. B., Bai Y. G., Li R. F., Li X. M., et al., Self-assembled nanoparticles of cholesterol-conjugated carboxymethyl curdlan as a novel carrier of epirubicin, Nanotech., 2010, 21, 265-601.
25. Bolcal C., Yildimir V., Doganci S., Sargin M., Aydin A., Eken A., et al., Protective effects of antioxidant medications on limb ischemia reperfusion injury, J. Surg. Res., 2007, 139, 274-279.
26. Berdal M., Appelbom H. I., Eikrem J. H., Lund Å., Zykova S., Busund L. T., et al., Aminated β-1, 3-glucan improves wound healing in diabetic db/db mice, Wound Rep. Reg., 2007, 15, 825-832.
27. Bohn J. A., BeMiller J. N., (1→3)-β-D-glucans as biological response modifiers: a review of structurefunctional activity relationships, Carbohydrate Polymers., 1995, 28, 3-14.
28. Oliveira R. J., Matuo R., da Silva A. F., Matiazi H. J., Mantovani M. S., Ribeiro L. R., Protective effect of β-glucan extracted rom Saccharomyces cerevisiae, against DNA damage and cytotoxicity in wild-type (k1) and repair-deficient (xrs5) CHO cells, Toxicology in Vitro, 2007, 21, 41-52.
29. Greinacher A., Alban S., Dummel V., Franz G., Mueller-Eckhardt C., Characterization of the structural requirements for a carbohydrate based anticoagulant with a reduced risk of inducing the immunological type of heparin-associated thrombocytopenia, Thromb. Haemost., 1995, 74, 886-892.
30. Morikawa K., Takeda R., Yamazaki M., Mizuno D., Induction of tumoricidal activity of polymorphonuclear leukocytes by a linear β-1, 3-D-glucan and other immunomodulators in murine cells, Cancer Res., 1985, 45, 1496-1501.
31. Bøgwald J., Gouda I., Hoffman J., Larm O., Larsson R., Seljelid R., Stimulatory effect of immobilized glycans on macrophages in vitro, Scand. J. Immunol., 1987, 20, 355-360.
32. Belcarz A., Ginalska G., Ślósarczyk A., Paszkiewicz Z., Bioactive composite and process for the production of the bioactive composite, Polish Patent PL-387872, 2009.
33. Belcarz A., Ginalska G., Ślósarczyk A., Paszkiewicz Z., Bioactive composite and process for the production of the bioactive composite, European Patent Office, EP 107266397, 2010.
34. Paszkiewicz Z., Ślósarczyk A., Zima A., Method for fabrication of highly porous, calcium phosphate bioactive implant material, Polish Patent PL-387530, 2009.
35. Kokubo T., Hushitani H., Sakka S., Kitsugi T., Yamamuro T., Solutions able to reproduce in vivo surface-structure changes in bioactive glassceramic A-W., J. Biomed. Mater. Res., 1990, 24, 721-734.
36. ISO 23317: 2007 (E), International Organization for Standardization (ISO), Implants for surgery - In vitro evaluation for apatite-forming ability of implant materials, Geneva: International Organization for Standardization, 2007.
37. Oliveira J. M., Rodrigues M. T., Silva S. S., Malayafa P. B., Gomes M. E., Viegas C. A., et al., Novel hydroxyapatite/chitosan bilayered scaffold for osteochondral tissue-engineering applications: Scaffold design and its performance when seeded with goat bone marrow stromal cells, Biomaterials, 2006, 27, 6123-6137.
38. Rapacz-Kmita A., Paluszkiewicz C., Ślósarczyk A., Paszkiewicz Z., FTIR and XRD investigations on the thermal stability of hydroxyapatite during hot pressing and pressureless sintering process, J. Mol. Structure, 2005, 744-747, 653-656.
39. Wang Y.-J., Yao S.-H., Guan Y.-X., Wu T.-X., Kennedy J. F., A novel process for preparation of (1→3)-β-D-glucan sulphate by a heterogeneous reaction and its structural elucidation, Carbohyd. Polym., 2005, 59, 93-99.
40. Jin Y., Zhang H., Yin Y., Nishinari K., Comparison of curdlan and its carboxymethylated derivative by means of Rheology, DSC and AFM, Carbohyd. Res., 2006, 341, 90-99.
41. Liu Y., Lu Y., Tian X., Cui G., Zhao Y., Yang Q., et al., Segmental bone regeneration using an rhBMP-2-loaded gelatin/nanohydroxyapatite/fibrin scaffold in a rabbit model, Biomaterials, 2009, 30, 6276-6285.
42. Linkow L. I., Implant dentistry today: a multidisciplinary approach, Vol. I. Piccin Nuova Libraria, Padua, Italy, 1990.
43. Ślósarczyk A., Ceramic biomaterials [Biomateriały ceramiczne], In: Błażewicz S., Stoch L. (Eds.), Biocybernetyka i Inżynieria Biomedyczna 2000, V. 1: Biomateriały, Akademicka Oficyna Wydawnicza EXIT, Warsaw, 2003 (in Polish).
44. Aoki H., Medical applications of hydroxyapatite, Ishiyaki EuroAmerica Inc, Tokyo St. Louis, 1994.
45. Zheng-Qiu G., Jiu-Mei X., Xiang-Hong Z., The development of artificial articular cartilage-PVAhydrogel, Biomed. Mater. Eng., 1998, 8, 75-81.
46. Magnussen R. A., Guilak F., Vail T. P., Cartilage degeneration in post-collapse cases of osteonecrosis of the human femoral head: altered mechanical properties in tension, compression and shear, J. Orthop. Res., 2005, 23, 576-583.
47. Suchanek W., Yoshimura M., Processing and properties of hydroxyapatite-based biomaterials for use as hard tissue replacement, J. Mater. Res., 1998, 13, 94-117.
48. Bonfield W., Bowman J. A., Grynpas M. D., Composite material for use in orthopaedics, US Patent 5017627, 1991.
49. Noah E. M., Chen J., Jiao X., Heschel L., Pallua N., Impact of sterilization on the porous design and cell behavior in collagen sponges prepared for tissue engineering, Biomaterials, 2002, 23, 2855-2861.
50. Kawashita M., Nakao M., Minoda M., Kim H. M., Beppu T., Miyamoto T., et al., Apatite-forming ability of carboxyl group-containing polymer gels in a simulated body fluid, Biomaterials, 2001, 24, 2477-2484.
51. Chen J., Duan Y., Zhang X., Effect of microstructure on osteoinductivity of biomaterials, Key Engin. Mater., 2005, 284-286, 289-292.
52. Habibovic P., Yuan H., van der Valk C. M., Meijer G., van Blitterswijk C. A., de Groot K., 3D microenvironment as essential element for osteoinduction by biomaterials, Biomaterials, 2005, 26, 3565-3575.
53. Hornez J.-C., Chai F., Monchau F., Blanchemain N., Descamps M., Hildebrandt H. F., Biological and physico-chemical assessment of hydroxyapatite (HA) with different porosity, Biomol. Engn., 2007, 24, 505-509.
54. Abrahams J. J., Berger S. B., Oral-maxillary sinus fistula (oroantral fistula): clinical features and findings on multiplanar CT, Am. Roentgen Ray Soc., 1995, 165, 1273-1276.
55. Liu Y. L., Schoenaers J., de Groot K., de Wijn J. R., Schepers E., Bone healing in porous implants: a histological and histometrical comparative study on sheep, J. Mater. Sci.: Mater. Med., 2000, 11, 711-717.
56. Lee S. B., Jeon H. W., Lee Y. W., Lee Y. M., Song K. W., Park M. H., et al., Bio-artificial skin composed of gelatin and (1→3), (1→6)-β-glucan, Biomaterials, 2003, 24, 2503-2511.
57. Khandwekar A. P., Patil D. P., Khandwekar V., Shouche Y. S., Sawant S., Doble M., TecoflexTM functionalization by curdlan and its effect on protein adsorption and bacterial and tissue cell adhesion, J. Mater. Sci. Mater. Med., 2009, 20, 1115-1129.
58. Sun Y., Liu Y., Li Y., Lv M., Li P., Xu H., et al., Preparation and characterization of novel curdlan/chitosan blending membranes for antibacterial applications, Carbohydrate Polymers, 2011, 84, 952-959.
59. Delatte S. J., Evans J., Hebra A., Adamson W., Otherson H. B., Tagge E. P., Effectiveness of betaglucan collagen for treatment of partial-thickness burns in children, J. Pediatric Surg., 2001, 36, 113-118.